pCSIIpuro-EKAREN5-gl-TA
(Plasmid
#258334)
-
PurposeNegative control TA mutant plasmid for EKAREN5-gl (Weisheng et al., doi: 10.1247/csf.24070.) with Puromycin resistance
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 258334 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backbonepCSII lentiviral vector
-
Vector typeLentiviral
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameEKAREN5-gl-TA
-
SpeciesSynthetic
-
Insert Size (bp)2049
- Promoter EF-1a
-
Tag
/ Fusion Protein
- nls localization motif (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site EcoRI (not destroyed)
- 3′ cloning site EcoRI (not destroyed)
- 5′ sequencing primer ACACGCTACCGGTCTC
- (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCSIIpuro-EKAREN5-gl-TA was a gift from Toru Hiratsuka (Addgene plasmid # 258334 ; http://n2t.net/addgene:258334 ; RRID:Addgene_258334) -
For your References section:
Quantitative Live Imaging Reveals Phase Dependency of PDAC Patient-Derived Organoids on ERK and AMPK Activity. Tsukamoto S, Huaze Y, Weisheng Z, Machinaga A, Kakiuchi N, Ogawa S, Seno H, Higashiyama S, Matsuda M, Hiratsuka T. Cancer Sci. 2025 Mar;116(3):724-735. doi: 10.1111/cas.16439. Epub 2024 Dec 27. 10.1111/cas.16439 PubMed 39731327